ASCEND CLINICAL RESEARCH Trademark

Trademark Overview


On Friday, February 10, 2017, a trademark application was filed for ASCEND CLINICAL RESEARCH with the United States Patent and Trademark Office. The USPTO has given the ASCEND CLINICAL RESEARCH trademark a serial number of 87331203. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, July 27, 2021. This trademark is owned by Ascend Innovations, Inc.. The ASCEND CLINICAL RESEARCH trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Providing site management activities in the field of clinical research in the nature of collecting, reposing, analyzing data to support scientific advancements and unmet clinical needs and prepare documentation for presentations to Institutional Review Boards, Subjects for consenting into trials and the Food and Drug Administration and managing data analytics for clinical research and studies conducted through an associated network of regional hospitals and healthcare organizations, including statistical analysis and reporting services for business purposes

Conduct training in the field of clinical research to Principal Investigators, Clinical Subjects, Sponsors and other persons; education services, namely, providing classes, seminars, and workshops to Principal Investigators, Clinical Subjects, Sponsors and other persons in the field of clinical research

Conducting medical device and pharmaceutical clinical studies and trials for others, namely, conducting early phase clinical research, observational studies and Phase I and II clinical trials for medical devices and pharmaceuticals; conducting clinical trials for others; providing clinical research information in the field of clinical trials, including data and information to support scientific advancements and unmet clinical needs for use with preparing documentation for presentations to Institutional Review Boards, Subjects for consenting into trials and the Food and Drug Administration
ascend clinical research

General Information


Serial Number87331203
Word MarkASCEND CLINICAL RESEARCH
Filing DateFriday, February 10, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, July 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"CLINICAL RESEARCH"
Goods and ServicesProviding site management activities in the field of clinical research in the nature of collecting, reposing, analyzing data to support scientific advancements and unmet clinical needs and prepare documentation for presentations to Institutional Review Boards, Subjects for consenting into trials and the Food and Drug Administration and managing data analytics for clinical research and studies conducted through an associated network of regional hospitals and healthcare organizations, including statistical analysis and reporting services for business purposes
Goods and ServicesConduct training in the field of clinical research to Principal Investigators, Clinical Subjects, Sponsors and other persons; education services, namely, providing classes, seminars, and workshops to Principal Investigators, Clinical Subjects, Sponsors and other persons in the field of clinical research
Goods and ServicesConducting medical device and pharmaceutical clinical studies and trials for others, namely, conducting early phase clinical research, observational studies and Phase I and II clinical trials for medical devices and pharmaceuticals; conducting clinical trials for others; providing clinical research information in the field of clinical trials, including data and information to support scientific advancements and unmet clinical needs for use with preparing documentation for presentations to Institutional Review Boards, Subjects for consenting into trials and the Food and Drug Administration

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2018
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2017
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 15, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAscend Innovations, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDayton, OH 45402

Trademark Events


Event DateEvent Description
Tuesday, July 27, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, July 27, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 5, 2021NON-FINAL ACTION E-MAILED
Tuesday, January 5, 2021NON-FINAL ACTION WRITTEN
Tuesday, November 10, 2020LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, May 8, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 30, 2020ASSIGNED TO LIE
Wednesday, October 30, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 4, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, September 25, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, February 27, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 27, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, February 27, 2018SUSPENSION LETTER WRITTEN
Tuesday, February 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 5, 2018ASSIGNED TO LIE
Friday, January 26, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 26, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 26, 2018NOTICE OF REVIVAL - E-MAILED
Friday, January 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 26, 2018PETITION TO REVIVE-GRANTED
Friday, January 26, 2018TEAS PETITION TO REVIVE RECEIVED
Tuesday, December 5, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, December 5, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 9, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2017NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2017NON-FINAL ACTION WRITTEN
Monday, May 8, 2017ASSIGNED TO EXAMINER
Wednesday, February 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 14, 2017NEW APPLICATION ENTERED IN TRAM